Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

46.51
-0.2300-0.49%
Post-market: 46.510.00000.00%19:39 EDT
Volume:2.14M
Turnover:99.98M
Market Cap:8.83B
PE:-13.16
High:47.36
Open:47.05
Low:46.14
Close:46.74
Loading ...
Jan 18, 2024

Major Issues Report

Form 8-K - Current report
Jan 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 09, 2024

Major Issues Report

Form 8-K - Current report
Jan 06, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 27, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 25, 2023

Major Issues Report

Form 8-K - Current report
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]